L. Morasca

1.1k total citations
63 papers, 850 citations indexed

About

L. Morasca is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, L. Morasca has authored 63 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 17 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in L. Morasca's work include Blood properties and coagulation (8 papers), Cancer Treatment and Pharmacology (8 papers) and Ovarian cancer diagnosis and treatment (7 papers). L. Morasca is often cited by papers focused on Blood properties and coagulation (8 papers), Cancer Treatment and Pharmacology (8 papers) and Ovarian cancer diagnosis and treatment (7 papers). L. Morasca collaborates with scholars based in Italy, United States and Netherlands. L. Morasca's co-authors include Jesse E. Sisken, Eugenio Erba, Maurizio D’Incalci, Silvio Garattini, Maria Benedetta Donati, Costantino Mangioni, Giorgio Bolis, Massimo Vaghi, Giovanna Balconi and E. Dolfini and has published in prestigious journals such as The Journal of Cell Biology, JNCI Journal of the National Cancer Institute and Journal of Medicinal Chemistry.

In The Last Decade

L. Morasca

60 papers receiving 774 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Morasca Italy 17 372 238 111 106 101 63 850
Carl G. Schmidt Germany 13 349 0.9× 265 1.1× 81 0.7× 84 0.8× 142 1.4× 33 798
Jean Harb France 19 482 1.3× 248 1.0× 96 0.9× 97 0.9× 72 0.7× 55 1.2k
Z. Mishal France 19 487 1.3× 157 0.7× 102 0.9× 64 0.6× 101 1.0× 32 922
C. J. Kovacs United States 18 240 0.6× 194 0.8× 81 0.7× 133 1.3× 37 0.4× 55 722
J A Hickman United States 14 361 1.0× 291 1.2× 109 1.0× 257 2.4× 57 0.6× 26 978
Harry Gregory United Kingdom 10 472 1.3× 196 0.8× 77 0.7× 77 0.7× 50 0.5× 12 1.1k
Yoshiyasu Kaneko Japan 15 511 1.4× 196 0.8× 76 0.7× 91 0.9× 144 1.4× 55 966
Seiichiro Tarui Japan 17 523 1.4× 118 0.5× 86 0.8× 57 0.5× 278 2.8× 40 1.3k
Tetsuo Nishiura Japan 22 640 1.7× 165 0.7× 61 0.5× 44 0.4× 341 3.4× 44 1.2k
D. A. Bradbury United Kingdom 18 453 1.2× 185 0.8× 64 0.6× 54 0.5× 304 3.0× 21 836

Countries citing papers authored by L. Morasca

Since Specialization
Citations

This map shows the geographic impact of L. Morasca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Morasca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Morasca more than expected).

Fields of papers citing papers by L. Morasca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Morasca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Morasca. The network helps show where L. Morasca may publish in the future.

Co-authorship network of co-authors of L. Morasca

This figure shows the co-authorship network connecting the top 25 collaborators of L. Morasca. A scholar is included among the top collaborators of L. Morasca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Morasca. L. Morasca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frascotti, Gianni, et al.. (1988). Characterization of Transformed Cell Lines Evolving from a Normal C3H Line. Pathobiology. 56(1-2). 20–28. 1 indexed citations
2.
Broggini, Massimo, Eugenio Erba, L. Morasca, Carmel M.T. Horgan, & Maurizio D’Incalci. (1986). In vivo studies with the novel anticancer agent mitozolomide (NSC 353451) on Lewis lung carcinoma. Cancer Chemotherapy and Pharmacology. 16(2). 125–8. 6 indexed citations
3.
Gambacorti‐Passerini, Carlo, et al.. (1985). Procoagulant activity of mouse and human cultured cells following various types of transformation. International Journal of Cancer. 35(3). 411–414. 9 indexed citations
4.
Morasca, L., Eugenio Erba, Massimo Vaghi, et al.. (1984). In vitro cytotoxicity of VP-16213 on human ovarian cancer.. Journal of Experimental & Clinical Cancer Research. 3(3). 305–311. 1 indexed citations
5.
Erba, Eugenio, et al.. (1984). Culture conditions induce the appearance of immortalized C3H mouse cell lines. In Vitro Cellular & Developmental Biology - Plant. 20(8). 597–601. 23 indexed citations
6.
Belloni, C, Costantino Mangioni, Silvestro Carinelli, et al.. (1983). ICRF 159 Plus Radiation Versus Radiation Therapy Alone in Cervical Carcinoma. Oncology. 40(3). 181–185. 4 indexed citations
7.
Guaitani, A., et al.. (1983). Two Lines of Walker Carcinoma 256: Their Peculiarities and Different Interactions with the Host. Tumori Journal. 69(1). 1–9. 16 indexed citations
8.
Vaghi, Massimo, S. Algeri, N. Brunello, et al.. (1982). Studies on a neuronal-like transport system for serotonin in two cell lines. Pharmacological Research Communications. 14(9). 851–859. 1 indexed citations
9.
D’Incalci, Maurizio, Eugenio Erba, Massimo Vaghi, & L. Morasca. (1982). In vitro cytotoxicity of VP 16 on primary tumor and metastasis of Lewis lung carcinoma. European Journal of Cancer and Clinical Oncology. 18(4). 377–380. 26 indexed citations
10.
Donati, Maria Benedetta, et al.. (1982). Fibrin clot retractile (FCR) activity of fibroblast-like cells from normal individuals and cancer patients. Cell Biology International Reports. 6(6). 609–618. 6 indexed citations
11.
Morasca, L., Silvia Marsoni, E. Piazza, et al.. (1980). Plasma levels of cyclophosphamide in patients under polychemotherapeutic regimens.. PubMed. 32(3). 123–7. 4 indexed citations
12.
Bolis, Giorgio, et al.. (1980). Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancer. Cancer Chemotherapy and Pharmacology. 4(2). 129–32. 24 indexed citations
13.
Balconi, Giovanna, et al.. (1980). Fibrin clot retractile activity of mouse fibroblasts during growth and aging. In Vitro Cellular & Developmental Biology - Plant. 16(9). 731–737. 15 indexed citations
14.
D’Incalci, Maurizio, Giorgio Bolis, C. Mangioni, L. Morasca, & Silvio Garattini. (1978). Variable oral absorption of hexamethylmelamine in man.. PubMed. 62(12). 2117–9. 29 indexed citations
15.
Dolfini, E., Bruno Azzarone, Emerenziana Ottaviano, et al.. (1976). Characterization of human fibroblasts from cancer patients: Loss of fibrin clot retractile activity after ‘in vitro’ spontaneous transformation. European Journal of Cancer (1965). 12(10). 823–825. 19 indexed citations
16.
Dolfini, E., et al.. (1976). Synthesis and anticancer activity of 5-diethylaminomethyl derivatives and nitrogen mustards of uracil and 2-thiouracils. Journal of Medicinal Chemistry. 19(5). 639–642. 8 indexed citations
17.
STEFANCICH, G., et al.. (1973). [Research on substances with antineoplastic activity. LII. Tylophorine analogs. I. Synthesis and cytostatic and cytotoxic activity of 4-(3,4-dimethoxyphenyl)piperidine derivatives].. PubMed. 28(5). 399–410. 1 indexed citations
18.
Morasca, L., et al.. (1972). Evaluation of the adhesion to glass of mammalian cells by an electronic particle counter. Cellular and Molecular Life Sciences. 28(10). 1263–1264.
19.
Morasca, L., Maurizio Rainisio, & G Masera. (1969). Duration of cytotoxic activity of vincristine in the blood of leukemic children. European Journal of Cancer (1965). 5(1). 79–80. 7 indexed citations
20.
Morasca, L.. (1965). Effect of triazolium derivatives on the growth of tissue cultured cells. European Journal of Cancer (1965). 1(2). 141–145. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl G. Schmidt Breakdown of academic impact, for papers by Jean Harb Breakdown of academic impact, for papers by Z. Mishal Breakdown of academic impact, for papers by C. J. Kovacs Breakdown of academic impact, for papers by J A Hickman Breakdown of academic impact, for papers by Harry Gregory Breakdown of academic impact, for papers by Yoshiyasu Kaneko Breakdown of academic impact, for papers by Seiichiro Tarui Breakdown of academic impact, for papers by Tetsuo Nishiura Breakdown of academic impact, for papers by D. A. Bradbury
Rankless by CCL
2026